StonvexLoading…
StonvexStonvexStonvexCore line items from VREX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-10-03 | Annual 2024 2024-09-27 | Annual 2023 2023-09-29 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $844.60M | $811.00M | $893.40M | $859.40M |
Operating Income | $-27.80M | $32.10M | $77.10M | $88.20M |
Net Income | $-70.30M | $-48.80M | $47.40M | $30.30M |
EPS (Diluted) | $-1.70 | $-1.20 | $1.07 | $0.73 |
Total Assets | $1.11B | $1.21B | $1.25B | $1.18B |
Total Liabilities | $620.80M | $670.40M | $668.60M | $637.70M |
Cash & Equivalents | $145.00M | $168.70M | $152.60M | $89.40M |
Free Cash Flow OCF − CapEx | $18.80M | $20.40M | $87.70M | $-4.40M |
Shares Outstanding | 41.69M | 41.09M | 40.53M | 40.09M |